{
    "clinical_study": {
        "@rank": "82534", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.   Collect data regarding the natural history of hereditary hemorrhagic\n      telangiectasia (HHT).\n\n      II.  Establish genotype-phenotype correlations in HHT. III. Create a database of information\n      for researchers throughout the world."
        }, 
        "brief_title": "Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients", 
        "condition": "Hereditary Hemorrhagic Telangiectasia", 
        "condition_browse": {
            "mesh_term": [
                "Telangiectasia, Hereditary Hemorrhagic", 
                "Telangiectasis"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Patients complete a self-administered natural history questionnaire in a\n      multiple choice format.   Questionnaire is completed by a population consisting of males and\n      females of all ages and ethnic backgrounds.\n\n      Data are collected and made available to all researchers."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Diagnosed hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) with\n             recurrent epistaxis, telangiectases, and visceral vascular anomalies"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "February 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004649", 
            "org_study_id": "199/11712", 
            "secondary_id": "UVT-650"
        }, 
        "keyword": [
            "genetic diseases and dysmorphic syndromes", 
            "hematologic disorders", 
            "hereditary hemorrhagic telangiectasia", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "University of Vermont", 
            "last_name": "Alan Guttmacher", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004649"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Vermont", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "May 1995", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "December 2001"
    }, 
    "geocoordinates": {}
}